Clinical Trial Update: A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating whether adding fianlimab to cemiplimab and chemotherapy improves safety and efficacy compared wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cemiplimab (cemiplimab)
• Chemotherapy (chemotherapy)
• Fianlimab (fianlimab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Resectable Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING